Trio Pharmaceuticals (Pre-Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- December 03, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $3,100,000
Company Info
- Founders
- Dr. Reiner Laus
- Company Description
- Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.
- Market
- Cancer Immunotherapy
- Location
- San Carlos, California, USA
- Coinvestors
- Friedman BioVentures, Life Science Angels, Myeloma Investment Fund, NuFund Venture Group